Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 26:8:690899.
doi: 10.3389/fmolb.2021.690899. eCollection 2021.

Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview

Affiliations
Review

Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview

Liena E O Elsayed et al. Front Mol Biosci. .

Abstract

Hereditary spastic paraplegias (HSP) are a heterogeneous group of motor neurodegenerative disorders that have the core clinical presentation of pyramidal syndrome which starts typically in the lower limbs. They can present as pure or complex forms with all classical modes of monogenic inheritance reported. To date, there are more than 100 loci/88 spastic paraplegia genes (SPG) involved in the pathogenesis of HSP. New patterns of inheritance are being increasingly identified in this era of huge advances in genetic and functional studies. A wide range of clinical symptoms and signs are now reported to complicate HSP with increasing overall complexity of the clinical presentations considered as HSP. This is especially true with the emergence of multiple HSP phenotypes that are situated in the borderline zone with other neurogenetic disorders. The genetic diagnostic approaches and the utilized techniques leave a diagnostic gap of 25% in the best studies. In this review, we summarize the known types of HSP with special focus on those in which spasticity is the principal clinical phenotype ("SPGn" designation). We discuss their modes of inheritance, clinical phenotypes, underlying genetics, and molecular pathways, providing some observations about therapeutic opportunities gained from animal models and functional studies. This review may pave the way for more analytic approaches that take into consideration the overall picture of HSP. It will shed light on subtle associations that can explain the occurrence of the disease and allow a better understanding of its observed variations. This should help in the identification of future biomarkers, predictors of disease onset and progression, and treatments for both better functional outcomes and quality of life.

Keywords: allelic variants; clinical spectrum; diagnostic gap; diagnostic yield; genetic heterogeneity; molecular mechanisms; phenotype-genotype correlation; spastic paraplegia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest, except a grant received by GS from Biogen, but unrelated to this work.

Figures

FIGURE 1
FIGURE 1
The main abnormal findings in MRI of the brain in different HSP subtypes. Font color codes correspond to various patterns of inheritance: AD HSP (green), AR HSP (violet), X-linked recessive (Blue), and Mixed AR/AD inheritance (red).
FIGURE 2
FIGURE 2
Regrouping of the age at onset of various HSP subtypes. The asterisk (*) indicates few exceptions in the age at onset range: SPG76*[one case is congenital] SPG72* and SPG77* has an age at onset range between (1–5 years)], SPG27 stands for the pure form and SPG27C for the complex form of SPG27. Font color codes represent the modes of inheritance: AD HSP (green), AR HSP (violet), X-linked recessive (Blue), Mitochondrial (brown), and Mixed AR/AD inheritance (red).
FIGURE 3
FIGURE 3
Intersections of HSP pathogenetic mechanisms highlighting the interplay between pathways. Font color codes correspond to various patterns of inheritance: AD HSP (green), AR HSP (violet), X-linked recessive (Blue), and Mixed AR/AD inheritance (red).

References

    1. Abdollahpour H., Alawi M., Kortüm F., Beckstette M., Seemanova E., Komárek V., et al. (2015). An AP4B1 Frameshift Mutation in Siblings with Intellectual Disability and Spastic Tetraplegia Further Delineates the AP-4 Deficiency Syndrome. Eur. J. Hum. Genet. 23, 256–259. 10.1038/ejhg.2014.73 - DOI - PMC - PubMed
    1. Abou Jamra R., Philippe O., Raas-Rothschild A., Eck S. H., Graf E., Buchert R., et al. (2011). Adaptor Protein Complex 4 Deficiency Causes Severe Autosomal-Recessive Intellectual Disability, Progressive Spastic Paraplegia, Shy Character, and Short Stature. Am. J. Hum. Genet. 88, 788–795. 10.1016/j.ajhg.2011.04.019 - DOI - PMC - PubMed
    1. Ahmed M. Y., Al-Khayat A., Al-Murshedi F., Al-Futaisi A., Chioza B. A., Pedro Fernandez-Murray J., et al. (2017). A Mutation of EPT1 (SELENOI) Underlies a New Disorder of Kennedy Pathway Phospholipid Biosynthesis. Brain 140, 547–554. 10.1093/brain/aww318 - DOI - PMC - PubMed
    1. Akawi N., McRae J., McRae J., Ansari M., Balasubramanian M., Blyth M., et al. (2015). Discovery of Four Recessive Developmental Disorders Using Probabilistic Genotype and Phenotype Matching Among 4,125 Families. Nat. Genet. 47, 1363–1369. 10.1038/ng.3410 - DOI - PMC - PubMed
    1. Al-Yahyaee S., Al-Gazali L. I., De Jonghe P., Al-Barwany H., Al-Kindi M., De Vriendt E., et al. (2006). A Novel Locus for Hereditary Spastic Paraplegia with Thin Corpus Callosum and Epilepsy. Neurology 66, 1230–1234. 10.1212/01.wnl.0000208501.52849.dd - DOI - PubMed